| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V89622 | [Au(TPP)]Cl | 15695-27-9 | [Au(TPP)]Cl inhibits the refolding activity of the Hsp60-Hsp10 complex and has anticancer activity. |
|
V127992 | A8 peptide | 1140483-17-5 | A8 peptide is an Hsp72 antagonist. |
|
V0877 | BIIB021 | 848695-25-0 | BIIB021 (CNF2024;BIIB-021; CNF-2024; CNF 2024; BIIB 021) is an orally bioavailable and purine-based small-molecule inhibitor of HSP90 (heat shock protein 90) with potential anticancer activity. |
|
V0883 | CH5138303 | 959763-06-5 | CH5138303 (CH 5138303; CH-5138303) is a novel, potent, orally boavailable HSP90 (Heat Shock Protein 90) inhibitor with potential anticancer activity. |
|
V52194 | DDO-5936 | 2355377-13-6 | DDO-5936 is a potent and specific Hsp90-Cdc37 PPI inhibitor. |
|
V133352 | DDO-6691 | 2640292-52-8 | DDO-6691 is a heat shock protein 90 (HSP90) inhibitor. |
|
V134297 | dPDL1-4 | dPDL1-4 is a highly efficient and selective eHSPTAC eHSP90 PD-L1 degrader with DC50 values of 7.77 μM and 6.52 μM in HeLa and B16F10 cells, respectively. | |
|
V136944 | Grp94 Inhibitor-3 | Grp94 Inhibitor-3 is a selective glucose-regulated protein 94 (Grp94) inhibitor with an affinity of 5.52 μM. | |
|
V2941 | HSF1A | 1196723-93-9 | HSF1A is acell-permeable andsmall-molecule activator of heat shock transcription factor 1 (HSF1). |
|
V106890 | Hsp90-IN-37 | 1383133-23-0 | Hsp90-IN-37 (Z-2) is a heat shock protein 90 (Hsp90) inhibitor, which inhibits Hsp90 enzyme activity by 69%. |
|
V0881 | HSP990 (NVP-HSP990) | 934343-74-5 | NVP-HSP990 (NVP HSP 990; NVP-HSP-990;HSP990; HSP-990) is an orally bioavailableHSP90 (heat shock protein 90) inhibitor with potential antitumor activity. |
|
V137721 | HYOU1-IN-1 | 2832155-52-7 | HYOU1-IN-1 is a hypoxia-upregulated protein 1 (HYOU1) inhibitor with anti-inflammatory activity. |
|
V53407 | Icapamespib (PU-HZ151) | 1000999-96-1 | Icapamespib (PU-HZ151) is a potent HSP90 inhibitor (antagonist) with EC50 of 5 nM. |
|
V55771 | JG-258 | 2241517-83-7 | JG-258 is an inactive negative control (NC) of an Hsp70 inhibitor. |
|
V0880 | KNK437 | 218924-25-5 | KNK437 (KNK-437; KNK 437; Heat Shock Protein Inhibitor I), abenzylidene lactam analog, is a novel and potentpan-HSP (heat shock proteins) inhibitor with potential antineoplastic activity. |
|
V2713 | KRIBB11 | 342639-96-7 | KRIBB11, a novel and potent inhibitor ofHeat shock factor 1 (HSF1), abolishes the heat shock-induced luciferase activity with an IC50 of 1.2 μM. |
|
V0889 | KW-2478 | 819812-04-9 | KW-2478 (KW 2478;KW2478) is a nonansamycin inhibitor of HSP90(Heat Shock Protein 90) with potential antitumor activity. |
|
V0884 | NMS-E973 | 1253584-84-7 | NMS-E973 (NMSE973; NMSE 973) is a novel, potent and selective HSP90 (Heat Shock Protein 90) inhibitor with potential antitumor activity. |
|
V0892 | NVP-BEP800 | 847559-80-2 | NVP-BEP800 (VER-82576; NVP BEP-800; BEP-800) is a novel, potent, fully synthetic, orally bioavailable heat shock protein 90β (HSP90β)inhibitor with potential antitumor activity. |
|
V55776 | Palmitic acid-1,2,3,4-13C4 (palmitic acid 13C4) | 287100-89-4 | Palmitic acid-1,2,3,4-13C4 is a 13C (carbon 13)-labeled Palmitic acid. |